Lungs News and Research

RSS

Three vaccine candidates race to combat SARS-CoV-2

As the coronavirus disease (COVID-19) ravages across the globe, scientists are racing to develop an effective vaccine to combat the viral infection. Caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the disease has infected nearly 9 million people.

22 Jun 2020

Favipiravir has weak effect on SARS-CoV-2 and Hydroxychloroquine none at all in hamster model

A new study from Belgian researchers shows that antiviral drug Favipiravir could have a weak effect against the dreaded novel coronavirus or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as seen in hamster models. However, the study also finds there is no efficacy of the much-touted drug Hydroxychloroquine.

22 Jun 2020

Researchers provide evidence-based review on COVID-19 respiratory transmission

In a new article, scientists provide an exhaustive, evidence-based review of how COVID-19 droplets from infected patients spread through the air and describe how health care professionals can protect themselves.

22 Jun 2020

Researchers develop new technique to print electronic sensors directly on organs

In groundbreaking new research, mechanical engineers and computer scientists at the University of Minnesota have developed a 3D printing technique that uses motion capture technology, similar to that used in Hollywood movies, to print electronic sensors directly on organs that are expanding and contracting.

22 Jun 2020

Direct structural link between SARS-CoV-2 and essential fatty acid

Now, a new study published on the preprint server bioRxiv in June 2020 reports the discovery of a novel free fatty acid (FFA) binding pocket on the SARS-CoV-2 virus that could explain in part the viral effects of hyperinflammation, immune modulation, and membrane structure.

21 Jun 2020

Balanced B and T cell response required to control SARS-CoV-2

A new study by researchers in the Netherlands and published on the preprint server bioRxiv in June 2020 describes the differences in T and B cell responses seen in patients with severe COVID-19.

21 Jun 2020

Near-infrared photoimmunotherapy could improve treatment for malignant lung cancer

Treating a rare type of malignant lung cancer could improve, thanks to near-infrared irradiation and a cancer-targeting compound. Nagoya University oncologist Kazuhide Sato and colleagues tested the treatment and published their findings in the journal Cells.

20 Jun 2020

Voice analysis by smartphone app detects lung congestion in heart failure patients

Voice analysis by a smartphone app identifies lung congestion in heart failure patients, allowing early intervention before their condition deteriorates.

19 Jun 2020

Developing betatron based medical complexes to reduce the chance of cancer recurrence

Tomsk Polytechnic University, JSC Academician M.F. Reshetnev Information Satellite Systems and the Polyus Research and Development Center will create the betatron based medical complexes, reducing the chance of cancer recurrence.

19 Jun 2020

How an ignored white blood cell may cause COVID-19 deaths

News-Medical speaks to Professor Lola Eniola-Adefeso about her research investigating how an ignored white blood cell may cause COVID-19 deaths.

19 Jun 2020

Discovery of biomarkers that can influence COVID-19 severity

The novel coronavirus, now called the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), is the causative agent of the dreaded coronavirus disease (COVID-19). It was first discovered in Wuhan City, China, back in late December 2019 and has since then spread throughout the globe.

19 Jun 2020

Researchers find prothrombotic antibodies in patients with COVID-19

Even as the COVID-19 pandemic continues to spread across the world, researchers are still trying to understand the many ways in which it can manifest and its pathogenesis. A new report published on the preprint server medRxiv* in June 2020 shows that one possible mechanism of disease in COVID-19 is the production of antiphospholipid antibodies.

19 Jun 2020

Nanosponges attract coronavirus away from lung cells, study shows

Imagine if scientists could stop the coronavirus infection in its tracks simply by diverting its attention away from living lung cells? A new therapeutic countermeasure, announced in a Nano Letters study by researchers from Boston University's National Emerging Infectious Diseases Laboratories and the University of California San Diego, appears to do just that in experiments that were carried out at the NEIDL in Boston.

18 Jun 2020

Conjunctivitis and keratoconjunctivitis can be possible primary symptoms of COVID-19

A case of pink eye is now reason to be tested for COVID-19, according to University of Alberta researchers.

18 Jun 2020

Multidisciplinary pediatric aerodigestive centers provide better outcomes with reduced costs

Children who choke when they drink or eat may have what's known as dysphagia, or a swallowing disorder -- one of the most common medical complaints seen in young children.

17 Jun 2020

Two clinical trials use low-dose X-rays to treat COVID-19 pneumonia

Previous studies have shown that low-dose, whole lung radiation in the form of X-rays can effectively treat severe pneumonia, with minimal side effects.

17 Jun 2020

Nanosponges could attack and neutralize SARS-COV-2 virus

Nanoparticles cloaked in human lung cell membranes and human immune cell membranes can attract and neutralize the SARS-CoV-2 virus in cell culture, causing the virus to lose its ability to hijack host cells and reproduce.

17 Jun 2020

Pandemic upends the lives of people with disabilities — and of their caregivers

When the COVID-19 pandemic hit, Stacy Ellingen, 34, of Oshkosh, Wisconsin, lost two of the three caregivers she depends on to dress, shower, eat and use the bathroom. The caregivers — both University of Wisconsin-Oshkosh students — returned to their parents’ homes when the university canceled in-person classes.

17 Jun 2020

Scientists isolate powerful SARS-CoV-2 -neutralizing antibodies from COVID-19 patients

A new study has shown that potent antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could help protect against COVID-19 infection. Preliminary results in animal studies have so far proven successful. The study titled, "Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model," was published in the latest issue of the journal Science.

17 Jun 2020

Severity of COVID-19 linked to heparanase activity and heparan sulfate levels

Researchers at Radboud University Medical Center in the Netherlands reported an increase of heparanase activity and heparan sulfate levels in the plasma of patients with coronavirus disease (COVID-19), which was also associated with the severity of the condition – suggesting, in turn, potential treatment utility of low molecular weight heparins. The paper is currently available on the medRxiv* preprint server.

16 Jun 2020

Lungs News and Research

Three vaccine candidates race to combat SARS-CoV-2

Favipiravir has weak effect on SARS-CoV-2 and Hydroxychloroquine none at all in hamster model

Researchers provide evidence-based review on COVID-19 respiratory transmission

Researchers develop new technique to print electronic sensors directly on organs

Direct structural link between SARS-CoV-2 and essential fatty acid

Balanced B and T cell response required to control SARS-CoV-2

Near-infrared photoimmunotherapy could improve treatment for malignant lung cancer

Voice analysis by smartphone app detects lung congestion in heart failure patients

Developing betatron based medical complexes to reduce the chance of cancer recurrence

How an ignored white blood cell may cause COVID-19 deaths

Discovery of biomarkers that can influence COVID-19 severity

Researchers find prothrombotic antibodies in patients with COVID-19

Nanosponges attract coronavirus away from lung cells, study shows

Conjunctivitis and keratoconjunctivitis can be possible primary symptoms of COVID-19

Multidisciplinary pediatric aerodigestive centers provide better outcomes with reduced costs

Two clinical trials use low-dose X-rays to treat COVID-19 pneumonia

Nanosponges could attack and neutralize SARS-COV-2 virus

Pandemic upends the lives of people with disabilities — and of their caregivers

Scientists isolate powerful SARS-CoV-2 -neutralizing antibodies from COVID-19 patients

Severity of COVID-19 linked to heparanase activity and heparan sulfate levels

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News